Olympios Papadimitriou is the President of the Hellenic Association of Pharmaceutical Companies (SFEE). He is also Vice President & General Manager at Novo Nordisk Hellas.
He started his career in the pharmaceutical sector in 1990, working as a sales representative for Wyeth, based in Thessaloniki.A couple of months later he joined Schering AG Berlin, nowadays absorbed by Bayer, where he had various responsibilities initially as sales representative, and at a later stage as regulatory affairs responsible and product manager. For that reason he moved to Athens.
He moved back to Thessaloniki in 1994 where he joined Novo Nordisk Hellas LTD as a sales representative. 6 years later he became a member of the diabetes marketing department in Novo Nordisk Hellas, based in Athens. His tenure at Novo Nordisk exceeds 24 years.
Olympios is a graduate of the German School of Thessaloniki and he holds a Diploma in Chemistry from Aristotelion University of Thessaloniki.
He has followed the Young Manager’s Programme at INSEAD and speaks fluently English and German.
Thursday 27
14.35 - 15.20
The EU Pharma Strategy and the Challenges for the Greek Healthcare Sector
Ahrweiler Hall | European Cultural Centre of Delphi
Programming Partner: Hellenic Association of Pharmaceutical Companies (SFEE)